TradingView's new rules for selling scripts: what changes on 15 November, 1 December and 1 February

TradingView published new terms for selling scripts on 6 November 2026, replacing the Marketplace-only rule it put on hold in October. Creators can keep selling access to their scripts, but private (invite-only style) scripts are capped at 5 users from 1 December, creators can start converting private scripts to public from 15 November, and seat-based billing for granting access starts on 1 February 2027. The source is TradingView's own post, Selling scripts on TradingView: the new terms.

The key dates

• 6 November 2026: the new terms apply. The 1 November Marketplace-only restriction announced in September won't take effect. See our earlier post on the rule being put on hold.
• 15 November 2026: creators can start converting private scripts to public.
• 1 December 2026: private scripts are capped at 5 users. A private script with more than 5 users is frozen for new users and updates until it is converted or cut back to 5 or fewer. Creators can make 5 new private scripts a month.
• By the end of December 2026: TradingView plans an Access API for granting and removing access. It is planned, not live.
• 1 February 2027: seat billing starts. Premium and higher plans include 100 seats, and each extra 100 seats costs $300 a month. Marketplace buyers and users of protected scripts don't use seats, and access granted before 1 February isn't charged unless it's extended.

The Marketplace fee is 0% for now, according to TradingView.

What's commonly misreported

• "$30 per user per month". Posts on X and some aggregators quote a per-user fee. TradingView's terms bill per 100 seats ($300 a month for each extra 100), not per user, and Marketplace buyers don't use seats.
• "Marketplace-only from 1 November". Some coverage still says this. TradingView changed course on 27 October and the new terms replace it.

What it means if you rent or sell a strategy

If you pay a vendor for access to a private script, check whether it has more than 5 users. If it does and the vendor doesn't convert it before 1 December, the script stops receiving updates and new users. Vendors with many customers will either move to public or protected scripts or start paying for seats from February, and some will pass that cost on.

It's a good moment to check whether a rented strategy is worth keeping. A script you can't see inside is hard to test properly. Our guide to testing an invite-only TradingView strategy before you rely on it shows how to export its Strategy Tester trades and check them by session, weekday and volatility.

If you want a strategy you own outright, you can describe the rules to TES, the AI strategy coach in Strategy Lab, backtest them with an unseen period and Monte Carlo, and export the result to TradingView as Pine Script v6 on paid plans, with no access to manage.

What to watch

• The Access API, planned for the end of December.
• Whether the terms on TradingView's policies page are updated to match the blog post.
• How large script vendors respond before 1 December.

This post will be updated as TradingView publishes more detail.